Prospective observational study to evaluate the safety and effectiveness of immunotherapy with an olive and grass pollen allergoid in patients with seasonal allergic asthma. GOL study
COMMERCIAL POST AUTHORIZATION STUDY
Clinical trial information
- Promoter: ALLERGY THERAPEUTICS IBERICA, SLU
- Execution start: 06/08/2021
- End of execution: 30/11/2022
- IP: JOSE FERNANDO FLORIDO LOPEZ